FDA Inspection 1266937 — Ailex Pharmaceuticals LLC

Ailex Pharmaceuticals LLC — FEI 3013703000

The FDA completed an inspection of Ailex Pharmaceuticals LLC on April 16, 2025 in Lenexa, KS. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 16, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lenexa, KS (United States)

Citations

IDCFRDescription
22921FDCA 582(b)(4)Systems in place to comply with verification requirements